Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

4.51
Delayed Data
As of May 01
 +0.25 / +5.87%
Today’s Change
1.56
Today|||52-Week Range
5.20
+98.68%
Year-to-Date

Today’s Trading

Previous close4.26
Today’s open4.27
Day’s range4.26 - 4.51
Volume701,365
Average volume (3 months)1,127,946
Market cap$397.1M
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-1.96%
Earnings growth (this year)+36.82%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales24.12
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+0.23+1.21%
NATRNatures Sunshine Pro...-0.01-0.08%
CYTKCytokinetics Inc-0.64-10.17%
CDTXCidara Therapeutics ...-0.70-4.79%
Data as of 4:00pm ET, 05/01/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$8.3M
Annual profit (last year)-$90.9M
Net profit margin-1,101.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers